Beijing Luzhu Biotechnology Co., Ltd. (HKG:2480)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.75
0.00 (0.00%)
Jun 18, 2026, 10:19 AM HKT
Market Cap2.54B -37.1%
Revenue (ttm)n/a
Net Income-167.32M
EPS-0.84
Shares Out 198.91M
PE Ration/a
Forward PE21.99
Dividendn/a
Ex-Dividend Daten/a
Volume5,400
Open12.75
Previous Close12.75
Day's Range12.75 - 12.75
52-Week Range12.00 - 28.00
Beta-0.73
AnalystsStrong Buy
Price Target31.29 (+145.41%)
Earnings DateAug 21, 2026

About HKG:2480

Beijing Luzhu Biotechnology Co., Ltd., a biotechnology company, develops human vaccines and therapeutic biologics to prevent and control infectious diseases, and to treat cancer and autoimmune diseases in Mainland China. The company is developing LZ901, a recombinant herpes zoster vaccine for which a biologics license application (BLA) has been submitted; K3, a recombinant human anti-tumor necrosis factor-alpha monoclonal antibody injection that has completed a Phase 1 clinical trial for the treatment of autoimmune diseases, such as rheumatoid ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2001
Employees 193
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2480
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements